1000993-70-3 Usage
Uses
Used in Pharmaceutical Research:
3-Amino-2-hydroxy-N,N-dimethylbenzamide Hydrochloride is used as an enzyme inhibitor for [application reason], leveraging its chemical properties to modulate biological processes and pathways. Its ability to inhibit specific enzymes can be crucial in the development of drugs targeting various diseases and conditions.
Used in Drug Development:
In the pharmaceutical industry, 3-Amino-2-hydroxy-N,N-dimethylbenzamide Hydrochloride is used as a lead compound for drug development. Its unique structure and functional groups make it a promising candidate for the creation of new medications, potentially leading to innovative treatments for a range of health issues.
Used in Chemical Synthesis:
3-Amino-2-hydroxy-N,N-dimethylbenzamide Hydrochloride is also used as a synthetic intermediate in the production of other chemical compounds. Its versatility in chemical reactions allows it to be a valuable component in the synthesis of various pharmaceuticals, agrochemicals, or other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1000993-70-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,9,9 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1000993-70:
(9*1)+(8*0)+(7*0)+(6*0)+(5*9)+(4*9)+(3*3)+(2*7)+(1*0)=113
113 % 10 = 3
So 1000993-70-3 is a valid CAS Registry Number.
1000993-70-3Relevant academic research and scientific papers
PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 1,2-SUBSTITUTED 3,4-DIOXO-1-CYCLOBUTENE COMPOUNDS
-
Page/Page column 35-36, (2009/03/07)
This application discloses a novel process for the preparation of 1.2 - substituted 3, 4 - dioxo - 1 - cyclobutene compounds of formula (A), which have utility, for example, in the treatment of CXC chemokine -mediated diseases, and intermediates useful in the synthesis thereof.
PROCESS FOR CONTROLLED CRYSTAL SIZE IN 1,2-SUBSTITUTED 3,4-DIOXO-1-CYCLOBUTENE COMPOUNDS
-
Page/Page column 25, (2009/03/07)
This application discloses a novel process for the preparation of 2-Hydroxy-N,N-dimethyl-3-[[2-[[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide, which has utility, for example, in the treatment of CXC chemokine-mediated diseases.
3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS
-
Page/Page column 72-73, (2008/06/13)
Disclosed are novel cyclobutenedione Compounds comprising a cycloclobutenedione ring, a substituted phenyl ring, and a -CH(C2H5)-furan moiety. The phenyl ring and the -CH(C2H5)-furan moiety are each bound to the
